Financhill
Sell
33

ENSC Quote, Financials, Valuation and Earnings

Last price:
$1.59
Seasonality move :
22.18%
Day range:
$1.55 - $1.65
52-week range:
$1.46 - $10.96
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.70x
P/B ratio:
4.71x
Volume:
68.9K
Avg. volume:
72.3K
1-year change:
-80.46%
Market cap:
$5.7M
Revenue:
$5.2M
EPS (TTM):
-$6.10

Earnings Data

Next earnings date for ENSC
--
Most recent earnings per share
-$1.29
Missed by $0.36
(Sep 30/2025)
Consensus Estimate
-$0.93
(Sep 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ENSC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2025 Q4 $503K -- -- -$0.72 --
09/30/2025 Q3 $1.4M $493.1K -$1.29 -$0.93 -$0.36
08/14/2025 Q2 $673.1K $1.4M -$0.79 -$1.28 $0.49
05/15/2025 Q1 -- $1.3M -$1.39 -$1.53 $0.14
03/10/2025 Q4 $245K $1.3M -$2.63 -$1.95 -$0.68
11/12/2024 Q3 $200K $3.4M $1.00 -- --
08/14/2024 Q2 $300K $181.8K -$3.35 -$5.25 $1.90
05/13/2024 Q1 $400K $305.7K -$8.21 -$11.25 $3.04
03/21/2024 Q4 $490K $515K -$16.71 -- --
11/09/2023 Q3 $593.3K $435.4K -$13.07 -- --
06/30/2023 Q2 -- $490.5K -$14.75 -- --
05/17/2023 Q1 -- $789.6K -$31.25 -- --
12/31/2022 Q4 -- $1.4M -$273.60 -- --
09/30/2022 Q3 -- $279.4K -$923.69 -- --
08/16/2022 Q2 -- $207.5K -$847.26 -- --
05/17/2022 Q1 -- $603.1K -$219.89 -- --
02/28/2022 Q4 -- $1.6M -$1,583.57 -- --
11/15/2021 Q3 -- $1.2M -$2,547.40 -- --
08/16/2021 Q2 -- $444.5K -$209.81 -- --
03/31/2021 Q1 -- $250.6K -$206.39 -- --
12/31/2020 Q4 -- $416.5K $48.28 -- --
09/30/2020 Q3 -- $827.6K $335.56 -- --
06/30/2020 Q2 -- $1.8M -$160.85 -- --
03/31/2020 Q1 -- -- $1,012.32 -- --
12/31/2019 Q4 -- -- -$198.83 -- --
09/30/2019 Q3 -- -- $70.63 -- --
06/30/2019 Q2 -- -- $60.44 -- --
03/31/2019 Q1 -- -- $111.78 -- --
12/31/2018 Q4 -- -- $104.15 -- --
09/30/2018 Q3 -- -- $83.23 -- --
06/30/2018 Q2 -- -- $59.83 -- --
03/31/2018 Q1 -- -- $58.50 -- --
12/31/2017 Q4 -- -- -$21.42 -- --
09/30/2017 Q3 -- -- -$2.88 -- --

Ensysce Biosciences, Inc. Earnings Questions

  • How Much did Ensysce Biosciences, Inc. Generate in Revenue Last Quarter?

    Ensysce Biosciences, Inc. reported $493.1K worth of top line sales in its most recent quarter.

  • Did Ensysce Biosciences, Inc. Beat Earnings Last Quarter?

    Ensysce Biosciences, Inc. announced earnings per share of -$1.29 which represents a miss of analyst forecast a -$0.93 per share.

  • Is Ensysce Biosciences, Inc. Profitable?

    Ensysce Biosciences, Inc. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Ensysce Biosciences, Inc. EPS Next Year?

    Ensysce Biosciences, Inc.'s earnings are forecast to decrease from -$11.45 per share to -$12.45 per share next year representing a decrease of -62.27%.

  • When is Ensysce Biosciences, Inc.'s Earnings Date?

    Currently, Ensysce Biosciences, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 10, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
67
GPCR alert for Dec 9

Structure Therapeutics, Inc. [GPCR] is up 102.52% over the past day.

Buy
62
SMX alert for Dec 9

SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.

Buy
90
KYMR alert for Dec 9

Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock